Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study

BACKGROUND: To evaluate the efficacy and safety of cabozantinib in Japanese patients with advanced hepatocellular carcinoma (HCC) who had progressed following one or two lines of systemic therapy including sorafenib. An exploratory evaluation in sorafenib-naïve patients was performed. METHODS: In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudo, Masatoshi, Tsuchiya, Kaoru, Kato, Naoya, Hagihara, Atsushi, Numata, Kazushi, Aikata, Hiroshi, Inaba, Yoshitaka, Kondo, Shunsuke, Motomura, Kenta, Furuse, Junji, Ikeda, Masafumi, Morimoto, Manabu, Achira, Meguru, Kuroda, Shingo, Kimura, Akiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article—Liver, Pancreas, and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862203/
https://www.ncbi.nlm.nih.gov/pubmed/33392749
http://dx.doi.org/10.1007/s00535-020-01753-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862203/
https://www.ncbi.nlm.nih.gov/pubmed/33392749
http://dx.doi.org/10.1007/s00535-020-01753-0

Ejemplares similares